Tarbox Family Office’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11
Closed -$1K 938
2022
Q1
$1K Buy
+11
New +$992 ﹤0.01% 1025
2020
Q4
Sell
-11
Closed -$1K 1195
2020
Q3
$1K Hold
11
﹤0.01% 1077
2020
Q2
$1K Hold
11
﹤0.01% 1077
2020
Q1
$1K Sell
11
-37
-77% -$2.57K ﹤0.01% 1013
2019
Q4
$4K Buy
+48
New +$3.54K ﹤0.01% 602

Other funds holding USNA

Tarbox Family Office's USNA Position: Q2 2022 in Review

Tarbox Family Office sold out of Usana Health Sciences (USNA) in Q2 2022, closing a stake of 11 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in USNA in Q4 2019 and held it in 5 quarters. The position peaked at $4K in Q4 2019. 182 funds tracked by Wall St. Rank hold USNA as of Q2 2022.

  • Tarbox Family Office reported no remaining Usana Health Sciences position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 11 Usana Health Sciences shares in Q2 2022, an estimated $1K.
  • Tarbox Family Office first reported a position in Usana Health Sciences in Q4 2019 and held it in 5 quarters.
  • Tarbox Family Office's Usana Health Sciences position peaked at $4K in Q4 2019.
  • 182 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.